Form D · Other Real Estate

NexPoint Life Sciences II DST

Dallas, TX · CIK 0001980223

Offering snapshot reported Nov 20, 2025 · SEC filing

Reported sold
$40.5M
Offering amount: $40.5M
Investors reported
112
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Jun 20, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$20.2M$40.5MSep 9, 2025: $36,996,318.00Sep 9, 2025Nov 7, 2025: $39,563,756.00Nov 7, 2025Nov 20, 2025: $40,489,695.00Nov 20, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$39,563,756 → $40,489,695
  • Reported investors109 → 112

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 20, 2025Amendment$40,489,695$925,939vs Nov 7, 2025112SEC filing
Nov 7, 2025Amendment$39,563,756$2,567,438vs Sep 9, 2025109SEC filing
Sep 9, 2025Amendment$36,996,318No comparison105SEC filing
Apr 21, 2025Amendment$31,059,027$2,028,231vs Dec 17, 202489SEC filing
Dec 17, 2024Amendment$29,030,796$1,166,766vs Oct 30, 202479SEC filing
Oct 30, 2024Amendment$27,864,030$8,432,853vs May 29, 202475SEC filing
May 29, 2024Amendment$19,431,177$22,064vs Apr 22, 202458SEC filing
Apr 22, 2024Amendment$19,409,113$610,942vs Apr 9, 202454SEC filing
Apr 9, 2024Amendment$18,798,171$7,515,754vs Dec 13, 202353SEC filing
Dec 13, 2023Amendment$11,282,417$1,094,175vs Nov 30, 202337SEC filing
Nov 30, 2023Amendment$10,188,242$456,383vs Nov 15, 202334SEC filing
Nov 15, 2023Amendment$9,731,859$2,062,082vs Oct 18, 202332SEC filing
Oct 18, 2023Amendment$7,669,777$1,339,020vs Sep 26, 202322SEC filing
Sep 26, 2023Amendment$6,330,757$3,503,360vs Sep 14, 202317SEC filing
Sep 14, 2023Amendment$2,827,397$1,066,690vs Aug 18, 202313SEC filing
Aug 18, 2023Amendment$1,760,707$761,485vs Jul 20, 20238SEC filing
Jul 20, 2023Amendment$999,222$477,842vs Jul 7, 20235SEC filing
Jul 7, 2023Amendment$521,380$100,000vs Jun 22, 20232SEC filing
Jun 22, 2023Initial$421,380No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06c, 3C, 3C.5
Duration over one year
No
Business combination
No
Sales commissions
$3.54M (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-484852
Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion.
Sales Commissions include estimates of the maximum amount of Selling Commissions and Dealer Fees that may be paid.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Emerson Equity LLC130032
Centaurus Financial, Inc.30833
Arkadios Capital282710
Coastal Equities, Inc.23769
DMK Advisor Group, Inc.41067
Concorde Investment Services, LLC151604
Great Point Capital LLC114203
Patrick Capital Markets, LLC16518
Infinity Financial Services144302
Lightpath Capital, Inc.34617
DFPG Investments, LLC155576
Realta Equities, Inc.23769
Innovation Partners LLC146344
Moloney Securities Co., Inc.38535
Realized Financial, Inc.22333
TCFG Wealth Management, LLC164153
Westpark Capital, Inc.108275
World Equity Group, Inc.29087
Aurora Securities46147
Saxony Securities, Inc.115547

Source: Form D, filed Nov 20, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Goetz Executive
Matt Mc Graner Executive
N/A Nex Point Real Estate Advisors Iv, L.P. Executive
N/A Nrea Life Sciences Ii, Llc Executive
N/A Nrea Ls Ii Investment Co, Llc Executive

Issuer details

Industry: Other Real Estate (See others in industry)

Address:
300 Crescent Court Suite 700
Dallas, TX, 75201